Walaa Obaid: How Warfarin Went From Poison To Medicine
Walaa Obaid, Former Pharmacist at Oman International Hospita, shared a post on LinkedIn:
”A substance originally developed as a deadly rat poison causing fatal internal bleeding… yet prescribed daily to millions of patients as a life-saving treatment!
Warfarin offers one of the most striking examples in pharmaceutical history that ‘the difference between a lethal toxin and a life-saving medicine lies in a precise understanding of human physiology and meticulously controlled dosing.’
First introduced in the 1940s as a potent rodenticide, clinical research later proved that at precisely calibrated doses, it safely inhibits the vitamin K epoxide reductase enzyme (VKORC1) in the liver. By reducing the synthesis of key clotting factors, it transforms from a rodent poison into a vital defense against:
- Stroke in patients with atrial fibrillation (AFib)
- Deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Thromboembolism in patients with mechanical heart valves
Pharmaceutical innovation isn’t always about discovering inherently harmless molecules from day one—it is also about taming dangerous compounds and carefully re-engineering them to guide patients safely away from life-threatening events.
Sources:
1. Journal of Thrombosis and Haemostasis: Historical documentation of Warfarin’s clinical evolution from a rodenticide to a frontline human anticoagulant.
2. U.S. FDA: Official prescribing information and clinical guidelines for Warfarin therapy and target INR monitoring.”
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 15:16Nathan Hutchinson-Jones: Pharmacist-Led Care Optimises Cancer-Associated Thrombosis
-
Oct 6, 2026, 14:46Counting Down to WTD With a Focus on Thrombosis in Pregnancy
-
Oct 6, 2026, 14:29Jorge Enrique: Navigating Anticoagulation in Pregnancy With a Prosthetic Heart Valve
-
Oct 6, 2026, 14:20Hassan Abdelhak: Understanding How LVADs Support the Failing Heart
-
Oct 6, 2026, 14:04Breast Imaging Insights From Madrid – Swiss Journal of Radiology and Nuclear Medicine
-
Oct 6, 2026, 13:10Vinicius Fornazari: New Perspectives In Interventional Radiology From SOBRICE
-
Oct 6, 2026, 12:39Sarah Garvey: Putting The Patient Experience At The Heart Of VTE Care
-
Oct 6, 2026, 12:33Platelets Without Donors: Can Freeze-Dried Artificial Platelets Transform Trauma Care?
-
Oct 6, 2026, 12:03Louise St. Germain Bannon: Supporting the World Thrombosis Day